RT Journal Article
T1 Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome.
A1 Roca Oporto, F J
A1 Rocha, Jose L
SN 2048-8505
YR 2021
FD 2021-12-09
LK http://hdl.handle.net/10668/19739
UL http://hdl.handle.net/10668/19739
LA en
DS RISalud
RD Apr 11, 2025